14 results
Murmurs Needing Echocardiography Evaluation #Management #EM #IM #Cardiology #Murmur #Benign #Characteristics #Echocardiogram #ALiEM
Evaluation #Management #EM ... #IM #Cardiology ... Echocardiogram #ALiEM
Common Causes of the Different Categories of Dizziness #Diagnosis #PrimaryCare #EM #IM #Differential #Dizziness #Vertigo #Disequilibrium
#PrimaryCare #EM ... #IM #Differential ... Lightheadedness #Table #NEJM
Pathogenesis of Nonalcoholic Steatohepatitis. Various factors, including inflammation, hyperinsulinemia or insulin resistance, and altered lipid homeostasis,
Pathophysiology #GI #IM ... #NASH #NAFLD #NonAlcoholicSteatoHepatitis ... NonAlcoholicFattyLiverDisease #NEJM
Cardiac etiologies of syncope (red line above) have the highest associated mortality! #EBM #EM #IM #Cardiology
#EBM #EM #IM #Cardiology ... Cardiac #Mortality #ALiEM
Nikolsky’s Sign - Febrile & Positive Nikolsky’s Sign: Patients in this group have the potential to
sick (Fever + Rash ... #Clinical #EM #IM
Stroke Rate by CHADS2 Score (Gage et al., JAMA, 2001) https://www.ncbi.nlm.nih.gov/pubmed/?term=11401607 #EBM #EM #IM #Cardiology #CHADS2
term=11401607 #EBM ... #EM #IM #Cardiology ... Score #StrokeRate #ALiEM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Secondary End Points #EBM ... #Neuro #IM #Fremanezumab ... CalcitoninGeneRelatedPeptideAntibody #Results #NEJM ... #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Adverse Events in the Safety Population, According
to Trial Group #EBM ... #Neuro #IM #Fremanezumab ... AdverseEvents #NEJM ... #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Secondary End Points #EBM ... #Neuro #IM #Fremanezumab ... CalcitoninGeneRelatedPeptideAntibody #NEJM
Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis - Incidence of New Vertebral, Clinical,
Nonvertebral Fracture #EBM ... PrimaryCare #Endo #IM ... #Alendronate #NEJM